Resource Library

See why the biggest barrier to home-based clinical monitoring is no longer device availability, but integrating multimodal biometric monitoring technologies into composite, fit-for-purpose digital measures.

See how biometric monitoring technologies in oncology have evolved from early activity tracking to today’s continuous monitoring approaches, and where the field is headed next.

Explore the EVIDENCE checklist, a multidisciplinary reporting standard designed to bring consistency and rigor to studies evaluating connected sensor technologies and digital measurement products.

Learn how applying the FDA’s biomarker qualification evidentiary criteria to remote cardiac safety monitoring could help sponsors detect cardiovascular liabilities earlier, before they become costly drug development attrition events.

Explore how two decades of laboratory biomarker validation experience is being applied to biometric monitoring technologies, offering a faster, more defensible path to fit-for-purpose digital biomarker qualification.

Learn why surface EMG, despite decades of research validation, still hasn’t become a routine tool in spinal cord injury rehabilitation, and what interdisciplinary steps could finally close that gap.

Explore why blood pressure is the only vital sign with internationally accepted validation protocols for biometric monitoring technologies, and what that validation gap means for trusting heart rate, respiratory rate, and oxygen saturation data collected at home.

Learn how at-home mobile spirometry achieved strong compliance and near-perfect agreement with clinic FEV1 measurements (r > 0.98) in a 12-patient asthma pilot study, while also boosting statistical power to detect treatment effects.

Explore the decision framework Koneksa Health developed for migrating clinical trial assessments from in-clinic to remote collection, weighing validity, safety, and regulatory implications rather than treating the shift as purely operational.